Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

575 results about "Lactobacillus casei" patented technology

Lactobacillus casei is a species of genus Lactobacillus found in the human urinary tract and mouth. This particular species of Lactobacillus is documented to have a wide pH and temperature range, and complements the growth of L. acidophilus, a producer of the enzyme amylase (a carbohydrate-digesting enzyme).

Five-union bacteria for conditioning and improving diarrhea, constipation and irritable bowel syndrome

The invention discloses a quintuple bacterium for conditioning and improving diarrhea, constipation and irritable bowel syndrome. The quintuple bacteria comprise lactobacillus reuteri HBM11-69, pediococcus pentosaceus MPL5, lactobacillus plantarum La-10, lactobacillus rhamnosus HBM11-35 and lactobacillus casei C7-2 bacteria, and the lactobacillus rhamnosus HBM11-35, the pediococcus pentosaceus MPL5, the lactobacillus plantarum La-10, the lactobacillus rhamnosus HBM11-35 and the lactobacillus The strain is found by a Lin Junjunch Teaching Team of South China Agricultural University. The probiotic composition disclosed by the invention is mutually matched and has a synergistic effect, and the intestinal flora structure balance can be effectively recovered by improving the small intestine propulsion rate, reducing the diarrhea frequency and the like. No matter in a viable or inactivated state, the traditional Chinese medicine composition has a relatively good improvement effect on gastrointestinal discomfort such as constipation and irritable bowel syndrome. The quintuplet compound probiotics are high in safety, do not cause adverse reactions such as electrolyte imbalance and can be used for preparing medicines or health foods or foods.
Owner:JIANMA PHARM (GUANGDONG) CO LTD

Lactobacillus paracasei JNL0025 and application thereof

The invention belongs to the technical field of microorganisms, and relates to a lactobacillus paracasei JNL0025 strain and application thereof. Compared with a commercial strain lactobacillus casei substitute strain, the lactobacillus paracasei JNL0025 provided by the invention has the advantages that the guanine nucleoside conversion rate is improved, the inhibition rate of supernate on XOD is equivalent, and the inhibition on PNP activity can be realized; according to the lactobacillus paracasei JNL0025 disclosed by the invention, the lactobacillus paracasei JNL0025 has the effects of reducing the tendency of pro-inflammatory M1 type macrophages, increasing the proportion of anti-inflammatory M2 type macrophages and inhibiting secretion of pro-inflammatory cytokines TNF-alpha and IL-6, and the lactobacillus paracasei JNL0025 has a better inflammation inhibition effect than the lactobacillus rhamnosus LGG; animal experiment results show that the lactobacillus paracasei JNL0025 provided by the invention can significantly reduce the blood uric acid level of a hyperuricemia model mouse, alleviate the kidney inflammation level and alleviate DSS-induced colitis, and shows a huge application value.
Owner:JINAN MICROECOLOGY & BIOMEDICINE PROVINCIAL LAB

Application of lactobacillus rhamnosus KF7 in improving intestinal barrier injury and regulating intestinal flora and functional food containing lactobacillus rhamnosus KF7

The invention relates to the technical field of microorganisms, in particular to application of lactobacillus rhamnosus KF7 in improving intestinal barrier injury and regulating intestinal flora and functional food containing the lactobacillus rhamnosus KF7. The invention provides application of lactobacillus rhamnosus KF7 in preparation of a product for improving intestinal barrier injury and / or regulating intestinal flora. The preservation number of the lactobacillus rhamnosus KF7 is CGMCC (China General Microbiological Culture Collection Center) NO.6430. The invention further provides application of the lactobacillus rhamnosus KF7 in preparation of a product for improving intestinal barrier injury and / or regulating intestinal flora. The invention discloses the novel application of the caseus rhamnosus KF7 in the aspects of improving the normal intestinal epithelial barrier function, protecting the normal intestinal epithelial barrier from lipopolysaccharide induced barrier injury, recovering animal intestinal barrier injury caused by rhythm disorder, regulating intestinal flora disorder and improving growth, development and metabolic states for the first time. The method can be used for producing functional food products such as fermented milk, lactic acid bacteria beverages, probiotic powder, viable bacteria water, milk powder and cheese.
Owner:BRIGHT DAIRY & FOOD CO LTD

Postbiotic preparation for pets as well as preparation method and application of postbiotic preparation

The invention belongs to the technical field of microorganisms, and particularly relates to a postbiotic preparation for pets as well as a preparation method and application of the postbiotic preparation. The metabolite preparation provided by the invention comprises a lactobacillus plantarum Ps-8 inactivated thallus and a metabolite thereof, a lactobacillus casei C-9 inactivated thallus and a metabolite thereof, a bifidobacterium animalis subsp. Lactis BB-16 inactivated thallus and a metabolite thereof, and a lactobacillus acidophilus LA-14 inactivated thallus and a metabolite thereof. The pet food can be applied to various food types of different varieties of cat and dog pets, and has the effects of improving the intestinal barrier function of the pets, enhancing the immunity, reducing the incidence rate of diarrhea, reducing the food change stress, promoting the digestion of nutrient substances, optimizing the state of spirit and fur, reducing the odor of excrement, fading the odor of the oral cavity, improving the health level of the oral cavity and teeth and the like.
Owner:INNER MONGOLIA KETUO MICRO-ECOLOGICAL TECH DEV CO LTD

Lactobacillus paracasei ZY and application thereof

The invention belongs to the technical field of microorganisms, and particularly relates to lactobacillus paracasei ZY and application thereof, and the preservation number of the lactobacillus paracasei ZY is CGMCC (China General Microbiological Culture Collection Center) No.30303. The invention provides the lactobacillus paracasei ZY capable of regulating the iron balance of intestinal tracts, and the lactobacillus paracasei ZY also can promote the growth of saccharomyces cerevisiae. The animal feed prepared from the lactobacillus paracasei ZY can regulate the iron absorption of intestinal tracts according to the iron content in blood, promote the intestinal tracts to autonomously regulate the iron balance, and effectively solve the problem of iron balance imbalance in large-scale production; a fermented product prepared from the lactobacillus paracasei ZY is good in palatability, digestion is promoted, and the immunity of the organism is enhanced.
Owner:FUJIAN NEW ZHENGYANG FEED TECH CO LTD

Probiotic and traditional Chinese medicine composition for treating insomnia and application

The invention discloses a composition for treating insomnia. Comprising probiotic compounds: lactobacillus plantarum, bifidobacterium lactis, lactobacillus crispatus, lactobacillus acidophilus, lactobacillus rhamnosus, bifidobacterium bifidum, lactobacillus reuteri, lactobacillus casei, lactobacillus bulgaricus, lactobacillus fermentum, lactobacillus gasseri, lactococcus lactis, bifidobacterium longum, lactobacillus salivarius, bifidobacterium breve, streptococcus thermophilus and lactobacillus paracasei; lactobacillus helveticus; and traditional Chinese medicine components and prebiotics. Probiotics are matched with traditional Chinese medicines with homology of medicine and food, and corresponding prebiotics are supplemented, so that the balance of intestinal flora can be adjusted and information transmission between intestines and cranial nerves can be promoted through the synergistic effect of the probiotics and the corresponding prebiotics, and then gastrointestinal inflammation, ulcer, helicobacter pylori infection, constipation and insomnia are treated or improved; and treating or improving spleen and stomach disharmony, liver qi stagnation, excessive heart fire, fire excess from yin deficiency, heart-kidney disharmony caused by emotion, pressure, diseases and the like, and insomnia caused by the symptoms.
Owner:BEIJING BAO YUAN GUANG TONG TECHNOLOGY DEVELOPMENT CO LTD

Lactobacillus casei, probiotic preparation for reducing generation of VSCs and application of probiotic preparation

The invention discloses a lactobacillus casei KC88, and the preservation number of the lactobacillus casei KC88 is CGMCC (China General Microbiological Culture Collection Center) No.32107. Meanwhile, the invention also discloses a screening process and application of the strain. According to the lactobacillus casei KC88 provided by the invention, the expression of a Cdl gene with fusobacterium nucleatum can be down-regulated, and the expression of a Mgl gene of porphyromonas gingivalis can be down-regulated. At the same time, the lactobacillus casei KC88 can inhibit the production of pathogenic bacteria biological membranes and reduce the production of volatile sulfides. And the inactivated surface protein of the casei casei KC88 can inhibit the formation of a pathogenic bacterium biological membrane. Therefore, the lactobacillus casei KC88 viable bacteria and the thermally inactivated bacteria have the effects of relieving breath and improving gastrointestinal functions, and can be applied to the fields of medicines, health care products and the like.
Owner:HUNAN NUTRITION TREE BIOTECHNOLOGY CO LTD

Comprehensive utilization method of corn processing waste resources

The invention belongs to the technical field of microbial fermentation, and particularly relates to a comprehensive utilization method of corn processing waste resources, which comprises the following steps: mixing corn steep liquor with calcium hydroxide, phytase and aspergillus oryzae SLY-M-15 leavening, carrying out enzymolysis, carrying out primary fermentation with corn bran, bacillus licheniformis, bacillus subtilis and saccharomyces cerevisiae, and carrying out secondary fermentation with corn bran, bacillus licheniformis, bacillus subtilis and saccharomyces cerevisiae; finally, lactobacillus fermentum and lactobacillus casei are inoculated for secondary fermentation, so that comprehensive utilization of the corn bran and the corn steep liquor is realized, and the contents of phytic acid, sulfite, zearalenone and vomitoxin are reduced; when the obtained third treatment product is applied to animal feed, the metabolism of mycotoxin can be influenced, and the content of zearalenone and vomitoxin can be reduced; further, the average daily gain can be improved, and the material-to-weight ratio is reduced; slaughtering performance can also be improved, for example, carcass weight, semi-eviscerating slaughtering rate and full eviscerating slaughtering rate are improved; the meat quality can be improved, such as the pH value is increased, the steaming loss is reduced, the shearing force is reduced, and the crude fat content is reduced.
Owner:山东泰山生力源集团股份有限公司

Bihalite-containing probiotic preparation for improving gastrointestinal environment and preparation method of bihalite-containing probiotic preparation

The invention provides a halite-containing probiotic preparation for improving gastrointestinal environment and a preparation method, the halite-containing probiotic preparation comprises the following components in parts by weight: 60-70 parts of a probiotic composition, the probiotic composition comprises lactobacillus casei Zhang, animal bifidobacterium subsp. Lactis V9, lactobacillus plantarum P-01, animal bifidobacterium subsp. Lactis B-01 and casei paracasei LC-11, the weight ratio is 3: 2: 2: 1: 1. 1.2 to 3.5 parts of nanoscale refined halite; 10 to 15 parts of a microcapsule embedding material; 0.6 to 1.2 parts of an antioxidant system; 15 to 30 parts of auxiliary materials; the probiotic preparation disclosed by the invention has the characteristics of obvious strain combination advantage, nano-scale halite protection and synergism, accurate release of a multi-layer microcapsule structure, synergistic effect of an antioxidant system and the like, the survival rate of probiotics, gastrointestinal tract tolerance and intestinal colonization capacity are remarkably improved, and a new technical scheme is provided for improving gastrointestinal health.
Owner:INNER MONGOLIA MENGYAN TECH CO LTD

Aquaculture denitrification microcapsule as well as preparation method and application thereof

ActiveCN119410543Areduce diseaseEfficient denitrificationBacteriaWater contaminantsBiotechnologyMetabolite
The invention discloses an aquaculture denitrification microcapsule as well as a preparation method and application thereof, and relates to the technical field of aquaculture and biology. The lactobacillus casei provided by the invention can secrete acid metabolites, and the acid metabolites can inhibit pathogenic vibrio, so that the occurrence of diseases in aquaculture can be reduced. Lactobacillus casei has the efficacy of efficiently degrading ammonia nitrogen and nitrite nitrogen in the aquaculture environment, and can continuously realize efficient cleaning of the aquaculture environment. In addition, the invention also provides a denitrification microcapsule which creates a more favorable microenvironment for the efficient denitrification strain, so that the repeated denitrification performance is more stably exerted, and the denitrification microcapsule can be repeatedly utilized.
Owner:POLY CORE BIOENGINEERING CO LTD

Bacterial agent for fermenting soybean milk, its application, soybean cheese stick and preparation method

The present invention belongs to the technical fields of biological bacterium agents and functional food processing. Specifically, it relates to a bacterium agent for soybean milk fermentation and its application, a soy cheese stick and a preparation method thereof. The bacterium agent for soybean milk fermentation provided by the present invention uses Lactobacillus helveticus HL88 and Lactobacillus casei BL25 in combination. It can not only quickly acidify the soy milk, shortening the coagulation time of soy cheese, but also more fully hydrolyze soy proteins, releasing more short peptides and amino acids. In particular, it can highly produce γ-aminobutyric acid (GABA), enhancing the fermentation effect and nutritional value of soybean milk. Further, the soy cheese food prepared by fermenting with the above bacterium agent not only has a strong soy milk fragrance and a smooth texture, but is also easily digested and absorbed, improving the digestibility and reducing the soybean allergenicity, especially helping to improve exercise fatigue and enhance sleep quality. Therefore, the above bacterium agent provided by the present invention has excellent application prospects in the field of preparing functional foods for anti-fatigue and promoting sleep.
Owner:NORTHEAST AGRICULTURAL UNIVERSITY

Antiseptic and bacteriostatic metabiotic composition for food as well as preparation method and application of preservative and bacteriostatic metabiotic composition

The invention belongs to the technical field of microorganisms, and particularly relates to a preservative and bacteriostatic metabiotic composition for food as well as a preparation method and application of the preservative and bacteriostatic metabiotic composition. The raw materials of the postbiotic composition comprise inactivated thalli of compound probiotics and metabolites of the compound probiotics; the compound probiotics comprise lactobacillus casei Zhang, bifidobacterium animalis subsp. Lactis V9, lactobacillus plantarum P-8 and lactobacillus plantarum PB-2. Through mutual cooperation of the four strains, a culture substrate can be more effectively converted into a plurality of organic acids and short-chain fatty acids with more excellent preservative and antibacterial effects, and the preservative and antibacterial effects of the post-biogen composition are improved.
Owner:内蒙古科拓生物有限公司

Lactobacillus casei M2b and application thereof

The invention belongs to the technical field of microorganisms, and particularly relates to a lactobacillus casei M2b and application thereof.The lactobacillus casei M2b is preserved in the China Center for Type Culture Collection with the preservation number of CCTCC NO: M20221748, the lactobacillus casei M2b can remarkably reduce the blood uric acid level and the whole-body inflammation level of mice at the same time, liver and kidney injuries caused by hyperuricemia can be relieved, and the lactobacillus casei M2b has the advantages that the lactobacillus casei M2b can be used for preventing and treating hyperuricemia; the strain can be used for improving intestinal flora disorder of mice with hyperuricemia, can be used for preparing functional microbial agents or medicines for preventing or relieving hyperuricemia and related symptoms thereof, and has a wide application prospect.
Owner:XINJIANG MEDICAL UNIV

A strain of Lactobacillus casei ZKLc1221, its lactobacillus and its application in improving ulcerative colitis

The present invention relates to the technical field of probiotics, and in particular to a strain of Lactobacillus casei ZKLc1221, its lactobacillus and its application in improving ulcerative colitis. Lactobacillus casei )ZKLc1221 has been deposited in the General Microbiology Center of China Microorganism Culture Collection Committee on June 21, 2023, with the deposit address at No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, and the deposit number is CGMCC No. 27673. The lactobacillus obtained by optimizing the fermentation conditions of Lactobacillus casei ZKLc1221 provided by the present invention has good thermal stability, good effect in improving ulcerative colitis, and can significantly improve pathological damage to the colon.
Owner:SHANDONG ZHONGWEI ZHONGKANG BIOTECHNOLOGY CO LTD

Compound probiotics for improving cognitive function of old people as well as preparation method and application of compound probiotics

The invention discloses a compound probiotic for improving cognitive function of old people and a preparation method and application thereof. Firstly, maltodextrin is dried and then sieved, metal impurities are removed after sieving, and maltodextrin freeze-dried powder, lactobacillus paracasei Lpc37 freeze-dried powder, phytobacterium plantarum Lp-115 freeze-dried powder and bifidobacterium animalis subsp. Lactis Bl-04 freeze-dried powder are weighed and sieved respectively; the preparation method comprises the following steps: preparing freeze-dried powder of three strains, then premixing the freeze-dried powder of the three strains with a part of maltodextrin, adding the residual maltodextrin after the strains are premixed, continuously mixing until the materials are uniformly distributed to obtain the compound probiotics, exerting a synergistic effect through a specific strain combination (Lp115 + Lpc37 + Bl-04), providing a new way for non-drug intervention, being beneficial to regulating intestinal flora metabolism (such as generating short-chain fatty acid SCFA), and improving the immunity of the human body. The synthesis and release of neurotrophic factors are promoted, the nerve cell function is improved, and the cognitive function improvement is indirectly assisted.
Owner:SHANGHAI FOURTH PEOPLES HOSPITAL

Lactobacillus casei GG002 and application of bacteriocin solution, freeze-dried powder and metagen thereof in treatment of oral ulcer

The invention provides a Lactobacillus casei GG002, a bacteriocin solution of the Lactobacillus casei GG002, freeze-dried powder of the Lactobacillus casei GG002 and application of the bacteriocin solution and the freeze-dried powder of the Lactobacillus casei GG002 to treatment of oral ulcer, and belongs to the technical field of microorganisms. The invention finds that the lactobacillus casei GG002 can inhibit streptococcus mutans, fusobacterium nucleatum and porphyromonas gingivalis, and has the effect of treating oral ulcer. The invention further provides a bacteriocin solution, freeze-dried powder and metagen of the casei casei GG002, and the bacteriocin solution, the freeze-dried powder and the metagen can be used for effectively treating the oral ulcer.
Owner:天津芯源生物科技有限公司 +1

Compound microorganism deodorization fungicide as well as preparation method and application thereof

The invention relates to a compound microorganism deodorization fungicide as well as a preparation method and application thereof, and belongs to the technical field of microorganism application. The invention provides a compound microorganism deodorization bacterium agent. The compound microorganism deodorization bacterium agent is prepared from bacillus cereus GXMU-Q5.3, streptomyces beihaiensis GXMU-J15 and lactobacillus paracasei GXMU-G1, the viable count ratio of the bacillus cereus GXMU-Q5.3 to the streptomyces beihaiensis GXMU-J15 to the lactobacillus paracasei GXMU-G1 is (1 to 2): (1 to 2): (1 to 2). The strain of the composite microbial deodorant agent is screened from soil and water at the stacking place of the marine product processing waste, the decomposition and deodorization effects on the marine product processing waste are obvious, the bacteria have a synergistic effect, and the deodorization effect of the composite microbial agent is improved by 40% or above compared with that of a single strain; the cost is low, the efficiency is high, the application range is wide, the deodorization period is short, and the safety is high.
Owner:GUANGXI UNIV FOR NATITIES +1

Probiotic composition for improving sleep and application

The invention relates to the technical field of microorganisms, in particular to a probiotic composition for improving sleep and application, and the probiotic composition comprises lactobacillus paracasei BMC-2020, lactobacillus plantarum MCA-3066, lactobacillus rhamnosus, lactobacillus fermentum and lactobacillus casei. The probiotic composition provided by the invention is safe and efficient, has a prospect of developing a new medicine for improving sleep, and has a clinical practical value; the probiotic composition is used for fermenting the traditional Chinese medicine composition, the obtained traditional Chinese medicine fermentation composition contains probiotics and traditional Chinese medicine fermentation liquor, the probiotics and the traditional Chinese medicine fermentation liquor can effectively achieve a synergistic effect, and the sleep improving efficacy of a traditional Chinese medicine fermentation product is promoted; the traditional Chinese medicine fermented composition can reduce the awakening activity amount and the total awakening time, and has the effect of improving sleep.
Owner:YUNNAN SAIYUAN BIOTECHNOLOGY CO LTD +1

Composite microecological preparation as well as preparation method and application thereof

The invention discloses a composite microecological preparation as well as a preparation method and application thereof. The compound microecological preparation disclosed by the invention comprises lactobacillus casei, lactobacillus plantarum and saccharomyces cerevisiae. The application effect of the composite microecological preparation in cow breeding is remarkable, the optimal addition amount of the composite microecological preparation is 100 mL / cow / day, the production performance of lactating cows can be improved, the milk yield is improved by 3.30 kg / cow / day, the milk yield of 4% standard milk is improved by 3.78 kg / cow / day, the total protein is improved by 15.9%, the albumin is improved by 14.7%, the globulin is improved by 16.5%, and the somatic cell number is reduced by 52.6%; and pollutant emission can be reduced, including 37.2% of ammonia emission reduction and 28.7% of carbon dioxide emission reduction.
Owner:JIANGSU ACAD OF AGRI SCI

Application of lactobacillus paracasei S1 in relieving acute liver injury

The invention discloses application of lactobacillus paracasei S1 in relieving acute liver injury, and belongs to the technical field of microorganisms. The invention aims to provide application of lactobacillus paracasei S1 separated from fresh rumen fluid and applied to a product for relieving acute liver injury in relieving acute liver injury. The lactobacillus paracasei S1 disclosed by the invention is preserved in the China General Microbiological Culture Collection Center (CGMCC), and the preservation number is CGMCC NO.33269. The lactobacillus paracasei S1 disclosed by the invention is a lactobacillus paracasei S1 strain. According to the lactobacillus paracasei S1 disclosed by the invention, AST, ALT, GGT and GDH activities of serum of mice with acute liver injury are reduced, and the condition of liver injury is improved. In conclusion, the lactobacillus paracasei S1 can be used for improving the acute liver injury or applied to feed, food and health care products, and a scientific basis is provided for developing functional products related to the lactobacillus paracasei S1 for improving the acute liver injury in the future.
Owner:JILIN UNIVERSITY

Application of lactobacillus casei or combined fungicide thereof in preparation of polypeptide through fermentation

The invention discloses application of lactobacillus casei or a combined microbial agent thereof to preparation of polypeptide through fermentation. The application comprises the step of preparing the polypeptide through combined fermentation of lactobacillus casei GYX-1 and lactobacillus delbrueckii subsp. Bulgaricus GYX-2. The method specifically comprises the following steps: diluting fermentation liquor obtained by fermenting in a carya illinoensis cake meal fermentation culture medium, and then performing ultrafiltration. The obtained hypoglycemic peptide does not need to be subjected to liquid chromatography separation, the amino acid sequence of the hypoglycemic peptide is directly analyzed by LC-MS / MS, the hypoglycemic peptide is synthesized to further verify the alpha-glucosidase inhibitory activity of the hypoglycemic peptide, the sequence of the hypoglycemic peptide is determined, and the efficiency is improved; the hypoglycemic peptide derived from the carya illinoensis cake meal can be used for preparing a functional preparation, and has hypoglycemic activity by inhibiting alpha-glucosidase.
Owner:NANJING NORMAL UNIVERSITY

Lactobacillus rhamnosus JM039 as well as composition and application thereof

The invention belongs to the technical field of probiotic products, and particularly relates to lactobacillus rhamnosus JM039 as well as a composition and application thereof. The preservation number of the lactobacillus rhamnosus JM039 is GDMCC No: 64409. The lactobacillus rhamnosus JM039 is a lactobacillus rhamnosus strain. The composition is prepared from lactobacillus reuteri J1, lactobacillus gasseri JM1, lactobacillus paracasei JY062, lactobacillus paracasei with the preservation number of GDMCC.No.62990, lactobacillus plantarum JY039 and lactobacillus rhamnosus JM039, and is prepared from lactobacillus reuteri J1, lactobacillus gasseri JM1, lactobacillus paracasei JY062, lactobacillus paracasei with the preservation number of GDMCC.No.62990, lactobacillus plantarum The combined bacteria of the six probiotics can improve the levels of anti-inflammatory factors and intestinal epithelium tight junction proteins and reduce the levels of proinflammatory factors and claudin-2 mRNA, so that the intestinal microenvironment homeostasis and intestinal barrier integrity are maintained through double regulation of inflammatory factors and tight junction proteins, and necrotizing enterocolitis can be relieved.
Owner:NORTHEAST AGRICULTURAL UNIVERSITY

Use and composition of postbiotic of lactobacillus paracasei et-22

The use and composition of a postbiotic of Lactobacillus paracasei ET-22, and the use of a lysate derived from Lactobacillus paracasei ET-22 in freshening breath and / or alleviating or inhibiting halitosis. The lysate is derived from heat-inactivated bacterial cells of Lactobacillus paracasei ET-22, the lysate at least comprises 2-hydroxy-3-phenylpropionic acid, NAD and a polypeptide, and the polypeptide has a structure as represented by formula 1. The postbiotic of and the lysate derived from Lactobacillus paracasei ET-22 can significantly reduce the contents of breath volatile sulfur compounds (VSCs) and salivary volatile organic compounds (VOCs) in the oral cavity, reduce the contents of characteristic flavor compounds, such as indoles, propionic acid and hexanoic acid, and can alter the oral microflora and inhibit the growth of oral biofilms and pathogenic bacteria, thus having the effects of freshening breath and alleviating or inhibiting halitosis.
Owner:INNER MONGOLIA YILI IND GROUP CO LTD

A postbiotic composition for anti-corrosion and antibacterial in food, its preparation method and application

The present invention belongs to the field of microbial technology, and specifically relates to a postbiotic composition for anti-corrosion and antibacterial in food, its preparation method and application. The raw materials of the postbiotic composition include: inactivated cells of a compound probiotic and metabolites of the compound probiotic; the compound probiotic includes Lactobacillus casei Zhang, Bifidobacterium animalis subsp. lactis V9, Lactobacillus plantarum P-8 and Lactobacillus plantarum PB-2. Through the mutual cooperation of the above four strains, the present invention can more effectively convert the culture medium substrate into several organic acids and short-chain fatty acids with more excellent anti-corrosion and antibacterial effects, improving the anti-corrosion and antibacterial effects of the postbiotic composition.
Owner:内蒙古科拓生物有限公司

Micromolecular renewing fermentation composition and application thereof

The invention provides a micromolecular renewal fermentation composition and application thereof, and belongs to the technical field of cosmetics. The fermentation composition comprises the following components in parts by weight: 95-99 parts of a composite plant fermentation concentrated solution and 1-5 parts of a protective agent, the compound plant fermentation concentrated solution is prepared by taking a rhizoma polygonati root extract, a poria cocos sclerotium extract, an avocado fruit extract and a ginseng root extract as compound plant raw materials, and fermenting the compound plant raw materials through compound lactobacillus to obtain a secondary metabolite; the composite lactobacillus is composed of at least two of lactobacillus plantarum, lactobacillus mucus fermentation, lactobacillus casei and lactobacillus acidophilus. The fermentation composition is prepared by fermenting multiple plant extracts, the multi-link anti-aging effect is remarkable, skin wrinkles are comprehensively improved through multiple ways of scavenging free radicals, promoting regeneration of type I collagen and elastin, resisting saccharification and the like, the anti-wrinkle and tightening effects are good, the good anti-inflammatory and soothing effects are achieved, safety is good, and the composition is suitable for being used for skin care. The application prospect in the field of beauty makeup or daily chemicals is wide.
Owner:珠海远大美业生物科技有限公司

Preparation method of fruit and vegetable juice beverage fermented by various probiotics

The invention discloses a preparation method of a fruit and vegetable juice beverage fermented by various probiotics in the field of food processing. The preparation method comprises the following steps: putting fruit and vegetable raw materials into auxiliary equipment, and performing high-pressure washing; the fruit and vegetable raw materials comprise cucumbers, dragon fruits, kiwi fruits and bananas; bifidobacterium, lactobacillus acidophilus, lactobacillus casei and lactobacillus plantarum are prepared and prepared into bacterial suspensions respectively, and then the bacterial suspensions are mixed in proportion to obtain a composite bacterial solution; cutting fruit and vegetable raw materials into blocks, performing low-pressure cooking, performing rapid cooling, performing juicing, and performing filtration so as to obtain fruit and vegetable juice raw materials; adding water and fructo-oligosaccharide into the fruit and vegetable juice raw material to form a fermentation base material, and then inoculating the composite bacteria liquid for fermentation to form a mixed raw material; and finally, storing to form the fruit and vegetable juice beverage. The preparation method of the fruit and vegetable juice beverage fermented by the various probiotics can adjust conditions and environments required by fermentation of the probiotics. Therefore, the fermented bean curd has the advantages of high nutritional value, good taste, sanitary preparation process, controllable fermentation process, reasonable storage mode and wide application range.
Owner:GUIZHOU PROVINCIAL MODERN AGRI DEV RES INST (GUIZHOU PROVINCIAL MODERN RURAL DEV RES CENT GUIZHOU PROVINCIAL RES INST OF RURAL ECONOMIC & SOCIAL DEV GUIZHOU PROVINCIAL AGRI PROD PROCESSING RES INST)

Probiotic stock solution capable of producing folic acid and SOD (superoxide dismutase) and having functions of reducing uric acid and reducing blood sugar and preparation method of probiotic stock solution

The invention relates to a probiotic stock solution capable of producing folic acid and SOD (superoxide dismutase) and having the functions of reducing uric acid and reducing blood sugar and a preparation method of the probiotic stock solution. Existing probiotic products are inconvenient to eat and do not have the effects of producing folic acid and SOD (superoxide dismutase). The probiotic stock solution contains the bifidobacterium animalis fermentation liquor, the lactobacillus paracasei fermentation liquor, the lactobacillus casei fermentation liquor, the lactobacillus fermentum fermentation liquor, the lactobacillus rhamnosus fermentation liquor and the lactobacillus reuteri fermentation liquor, and the final product is in a liquid state, can be packaged by small strip bags, and is relatively convenient to refrigerate, store and use. The probiotic stock solution disclosed by the invention not only has the effects of reducing uric acid and reducing blood sugar, but also generates water-soluble vitamin folic acid and superoxide dismutase SOD in the preparation and fermentation process, has the effects of resisting oxidation and aging after being taken into a human body, is suitable for pregnant women to take, and can reduce the risk of fetal neural tube defect.
Owner:XIAN INT MEDICAL BIOTECHNOLOGY CO LTD

Combination containing bacillus subtilis and lactobacillus casei and application of combination in soybean meal fermentation

PendingCN119242469AImprove degradation rateIncrease contentFungiBacteriaIntracellular metaboliteBacilli
The invention discloses a compound preparation, the compound preparation contains bacillus subtilis and lactobacillus casei, the bacillus subtilis is bacillus subtilis, the strain number of the bacillus subtilis is YB-10, the bacillus subtilis is preserved in the China General Microbiological Culture Collection Center (CGMCC), the preservation number is CGMCC NO.21103, and the lactobacillus casei is preserved in the China General Microbiological Culture Collection Center (CGMCC). The lactobacillus casei is lactobacillus casei, the strain number of the lactobacillus casei is TD01, the lactobacillus casei is preserved in the China Center for Type Culture Collection, and the preservation number of the lactobacillus casei is CCTCC NO: M 2022104. The bacillus subtilis YB-10 disclosed by the invention has a very high degradation rate on antigen protein in soybean meal, and can accumulate high-content acid soluble protein under the condition of solid state fermentation; the lactobacillus casei TD01 disclosed by the invention has a very good degradation effect on stachyose and raffinose in soybean meal; an intracellular metabolite obtained after autolysis of the lactobacillus casei TD01 cell has relatively high aminopeptidase activity, and bitter taste caused by accumulation of high acid soluble protein can be effectively removed.
Owner:HUBEI LANGUZHONG MICROBIAL TECH CO LTD +1

Lacticaseibacillus paracasei DG(r) CNCM i-1572 DSM 34154 for use in a method of treating dysbiosis in patients with ibs

The object of the present invention is to use the strain of bacteria named Lacticaseibacillus paracasei DG® CNCM I-1572 DSM 34154 for use in a method of treating dysbiosis, particularly in patients with IBS (Irritable Bowel Syndrome), preferably without constipation, who have high fecal levels of Collinsella aerofaciens.
Owner:ALFASIGMA SPA